Literature DB >> 14670447

Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5.

Sae Kyung Lee1, Allison Stack, Elena Katzowitsch, Shin Ichi Aizawa, Sebastian Suerbaum, Christine Josenhans.   

Abstract

Helicobacter pylori is a flagellated chronic pathogen, which colonizes the gastric mucus and mucosal cell surfaces. Flagella and motility are essential for the survival of this bacterium in the stomach environment. Flagellins of several bacterial species are potent activators of the human innate immune system by binding to TOLL-like receptor 5 (TLR5). The possible role of the two H. pylori flagellins FlaA and FlaB in stimulation of the innate immune system and induction of IL-8 release by human gastric epithelial cells was investigated in this study. Transcription and expression of TLR5 in three different human gastric epithelial cell lines was demonstrated. Salmonella enterica serovar Typhimurium FliC flagellin was able to activate human gastric epithelial cells. TLR5 transcription was modulated by H. pylori infection. However, both H. pylori flagellins appeared to possess no immunostimulatory potential on human gastric cells via TLR5, despite their extensive amino acid homology to stimulating flagellins of other bacterial species. The evolutionary development of such unique flagellins of low activating potential is proposed to be a novel mechanism of H. pylori to preserve the essential function of its flagella during chronic colonization of the stomach and to evade the deleterious host immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670447     DOI: 10.1016/j.micinf.2003.09.018

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  59 in total

Review 1.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  How flagellin and toll-like receptor 5 contribute to enteric infection.

Authors:  Theodore S Steiner
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  Toll like receptor-5: protecting the gut from enteric microbes.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Andrew T Gewirtz
Journal:  Semin Immunopathol       Date:  2007-12-07       Impact factor: 9.623

Review 4.  Synthetic DNA vaccine strategies against persistent viral infections.

Authors:  Daniel O Villarreal; Kendra T Talbott; Daniel K Choo; Devon J Shedlock; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

5.  The potential role of N-acetylcysteine for the treatment of Helicobacter pylori.

Authors:  Kian Makipour; Frank K Friedenberg
Journal:  J Clin Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 3.062

Review 6.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

7.  Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.

Authors:  Ludwig Deml; Michael Aigner; Jochen Decker; Alexander Eckhardt; Christian Schütz; Peer R E Mittl; Sascha Barabas; Stefanie Denk; Gertrud Knoll; Norbert Lehn; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 8.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 9.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

Review 10.  Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system.

Authors:  Russell E Vance; Ralph R Isberg; Daniel A Portnoy
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.